-
Je něco špatně v tomto záznamu ?
Optical coherence tomography in STEMI with bioresorbable scaffold: possible cause of coronary flow impairment? A sub-study from the Prague 19 trial
M. Loffi, P. Tousek, T. Budesinsky, L. Lisa, A. Santangelo, P. Widimsky, V. Kocka,
Jazyk angličtina Země Japonsko
Typ dokumentu časopisecké články, multicentrická studie, randomizované kontrolované studie
NLK
ProQuest Central
od 2000-01-01 do 2018-12-31
Medline Complete (EBSCOhost)
od 2003-03-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 2000-01-01 do 2018-12-31
- MeSH
- časové faktory MeSH
- everolimus farmakologie MeSH
- infarkt myokardu s elevacemi ST úseků diagnóza patofyziologie chirurgie MeSH
- koronární angiografie MeSH
- koronární angioplastika MeSH
- koronární cévy diagnostické zobrazování chirurgie MeSH
- koronární cirkulace fyziologie MeSH
- lidé MeSH
- optická koherentní tomografie metody MeSH
- prospektivní studie MeSH
- protézy - design MeSH
- regionální krevní průtok fyziologie MeSH
- stenty uvolňující léky MeSH
- tkáňové podpůrné struktury * MeSH
- vstřebatelné implantáty * MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- randomizované kontrolované studie MeSH
This study assessed the Optical Coherence Tomography (OCT) impact on the coronary flow in ST-elevation myocardial infarction (STEMI) after bioresorbable scaffold implantation. Only few data about OCT use in STEMI are available and coronary flow before and after OCT is not well studied yet. 54 patients with OCT performed at the end of procedure from the Prague 19 trial were selected and coronary flow was evaluated as TIMI frame count (TFC) before and just after OCT. Significant increase in TIMI frame count after OCT [from 9.5 (6.75-12.25) to 11.5 (8-15.25) frames; p = 0.001] and high verapamil administration (18%) was reported. OCT at the end of primary percutaneous coronary intervention with bioresorbable scaffold is a feasible procedure. However, it seems to be associated with flow deterioration.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19012658
- 003
- CZ-PrNML
- 005
- 20190409151347.0
- 007
- ta
- 008
- 190405s2018 ja f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00380-018-1184-7 $2 doi
- 035 __
- $a (PubMed)29777297
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ja
- 100 1_
- $a Loffi, Marco $u Cardiology Clinic, Dipartimento di Scienze Cliniche e di Comunità, UO Malattie Cardiovascolari, Fondazione IRCCS, Ospedale Maggiore Policlinico, University of Milan, Via Francesco Sforza 35, 20122, Milan, Italy. loffi.marco@gmail.com.
- 245 10
- $a Optical coherence tomography in STEMI with bioresorbable scaffold: possible cause of coronary flow impairment? A sub-study from the Prague 19 trial / $c M. Loffi, P. Tousek, T. Budesinsky, L. Lisa, A. Santangelo, P. Widimsky, V. Kocka,
- 520 9_
- $a This study assessed the Optical Coherence Tomography (OCT) impact on the coronary flow in ST-elevation myocardial infarction (STEMI) after bioresorbable scaffold implantation. Only few data about OCT use in STEMI are available and coronary flow before and after OCT is not well studied yet. 54 patients with OCT performed at the end of procedure from the Prague 19 trial were selected and coronary flow was evaluated as TIMI frame count (TFC) before and just after OCT. Significant increase in TIMI frame count after OCT [from 9.5 (6.75-12.25) to 11.5 (8-15.25) frames; p = 0.001] and high verapamil administration (18%) was reported. OCT at the end of primary percutaneous coronary intervention with bioresorbable scaffold is a feasible procedure. However, it seems to be associated with flow deterioration.
- 650 12
- $a vstřebatelné implantáty $7 D020341
- 650 _2
- $a koronární angiografie $7 D017023
- 650 _2
- $a koronární cirkulace $x fyziologie $7 D003326
- 650 _2
- $a koronární cévy $x diagnostické zobrazování $x chirurgie $7 D003331
- 650 _2
- $a stenty uvolňující léky $7 D054855
- 650 _2
- $a everolimus $x farmakologie $7 D000068338
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a koronární angioplastika $7 D062645
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a protézy - design $7 D011474
- 650 _2
- $a regionální krevní průtok $x fyziologie $7 D012039
- 650 _2
- $a infarkt myokardu s elevacemi ST úseků $x diagnóza $x patofyziologie $x chirurgie $7 D000072657
- 650 _2
- $a časové faktory $7 D013997
- 650 12
- $a tkáňové podpůrné struktury $7 D054457
- 650 _2
- $a optická koherentní tomografie $x metody $7 D041623
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 700 1_
- $a Tousek, Petr $u Cardiocenter, Third Faculty of Medicine, University Hospital Kralovske Vinohrady, Charles University, Prague, Czech Republic.
- 700 1_
- $a Budesinsky, Tomas $u Cardiocenter, Third Faculty of Medicine, University Hospital Kralovske Vinohrady, Charles University, Prague, Czech Republic.
- 700 1_
- $a Lisa, Libor $u Cardiocenter, Third Faculty of Medicine, University Hospital Kralovske Vinohrady, Charles University, Prague, Czech Republic.
- 700 1_
- $a Santangelo, Andrea $u Department of Cardiology, University of Palermo, Palermo, Italy.
- 700 1_
- $a Widimsky, Petr $u Cardiocenter, Third Faculty of Medicine, University Hospital Kralovske Vinohrady, Charles University, Prague, Czech Republic.
- 700 1_
- $a Kocka, Viktor $u Cardiocenter, Third Faculty of Medicine, University Hospital Kralovske Vinohrady, Charles University, Prague, Czech Republic.
- 773 0_
- $w MED00009797 $t Heart and vessels $x 1615-2573 $g Roč. 33, č. 11 (2018), s. 1282-1287
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29777297 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20190409151401 $b ABA008
- 999 __
- $a ok $b bmc $g 1391968 $s 1050963
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 33 $c 11 $d 1282-1287 $e 20180518 $i 1615-2573 $m Heart and vessels $n Heart Vessels $x MED00009797
- LZP __
- $a Pubmed-20190405